- Home
- ARBK vs NEPH Comparison
ARBK vs NEPH Comparison
Compare ARBK & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- NEPH
- Stock Information
- Founded
- ARBK 2017
- NEPH 1997
- Country
- ARBK United Kingdom
- NEPH United States
- Employees
- ARBK N/A
- NEPH N/A
- Industry
- ARBK Finance: Consumer Services
- NEPH Medical/Dental Instruments
- Sector
- ARBK Finance
- NEPH Health Care
- Exchange
- ARBK Nasdaq
- NEPH Nasdaq
- Market Cap
- ARBK 20.1M
- NEPH 16.8M
- IPO Year
- ARBK 2021
- NEPH 2004
- Fundamental
- Price
- ARBK $0.42
- NEPH $3.38
- Analyst Decision
- ARBK Hold
- NEPH Buy
- Analyst Count
- ARBK 1
- NEPH 1
- Target Price
- ARBK N/A
- NEPH $5.00
- AVG Volume (30 Days)
- ARBK 534.8K
- NEPH 28.8K
- Earning Date
- ARBK 05-15-2025
- NEPH 05-08-2025
- Dividend Yield
- ARBK N/A
- NEPH N/A
- EPS Growth
- ARBK N/A
- NEPH N/A
- EPS
- ARBK N/A
- NEPH 0.08
- Revenue
- ARBK $47,017,000.00
- NEPH $15,517,000.00
- Revenue This Year
- ARBK $183.90
- NEPH $17.06
- Revenue Next Year
- ARBK $26.78
- NEPH $12.20
- P/E Ratio
- ARBK N/A
- NEPH $43.73
- Revenue Growth
- ARBK N/A
- NEPH 10.34
- 52 Week Low
- ARBK $0.15
- NEPH $1.36
- 52 Week High
- ARBK $1.99
- NEPH $3.66
- Technical
- Relative Strength Index (RSI)
- ARBK 49.62
- NEPH 78.03
- Support Level
- ARBK $0.33
- NEPH $3.26
- Resistance Level
- ARBK $0.44
- NEPH $3.66
- Average True Range (ATR)
- ARBK 0.05
- NEPH 0.28
- MACD
- ARBK -0.00
- NEPH 0.08
- Stochastic Oscillator
- ARBK 76.90
- NEPH 86.96
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a data center business that provides a powerful and efficient platform for cryptocurrency mining operations. The company has operations in strategic locations in North America.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.